Publications by authors named "Jun Gui"

Article Synopsis
  • The PD-1/PD-L1 axis prevents T cell activity, which reduces the immune system's ability to fight tumors, making it a target for cancer therapies.
  • Blocking this axis with therapeutic antibodies has shown promise in reviving exhausted T cells within tumors, but new research is expanding the understanding of how these treatments affect a broader range of cells beyond just T cells.
  • The review highlights the need for further studies to explore these dynamics and discusses the potential clinical implications of the updates on cancer immunotherapy.
View Article and Find Full Text PDF

Tumors employ diverse strategies for immune evasion. Unraveling the mechanisms by which tumors suppress anti-tumor immunity facilitates the development of immunotherapies. Here, we have identified tumor-secreted fibroblast growth factor 21 (FGF21) as a pivotal immune suppressor.

View Article and Find Full Text PDF

Tumor microenvironment (TME)-induced nanocatalytic therapy is a promising strategy for cancer treatment, but the low catalytic efficiency limits its therapeutic efficacy. Single-atom catalysts (SACs) are a new type of nanozyme with incredible catalytic efficiency. Here, a single-atom manganese (Mn)-N/C nanozyme is constructed.

View Article and Find Full Text PDF

While ectonucleotidase CD39 is a cancer therapeutic target in clinical trials, its direct effect on T-cell differentiation in human non-small-cell lung cancer (NSCLC) remains unclear. Herein, we demonstrate that human NSCLC cells, including tumor cell lines and primary tumor cells from clinical patients, efficiently drive the metabolic adaption of human CD4 T cells, instructing differentiation of regulatory T cells while inhibiting effector T cells. Of importance, NSCLC-induced T-cell mal-differentiation primarily depends on cancer CD39, as this can be fundamentally blocked by genetic depletion of CD39 in NSCLC.

View Article and Find Full Text PDF
Article Synopsis
  • Low-dose metronomic (LDM) chemotherapy is gaining attention as a novel approach due to its ability to stimulate the immune system, particularly activating CD8T cells.
  • The mechanism behind LDM's effectiveness involves the production of oxidative stress in cancer cells, leading to the release of signals that enhance the immune response and increase the expression of PD-L1, which could improve outcomes in chemoimmunotherapy.
  • Antioxidants like N-acetylcysteine can hinder this process, suggesting that targeting the oxidative stress pathway could be crucial in optimizing cancer treatment strategies.
View Article and Find Full Text PDF

While previous studies have identified cancer stem-like cells (CSCs) as a crucial driver for chemoresistance and tumor recurrence, the underlying mechanisms for populating the CSC pool remain unclear. Here, we identify hypermitophagy as a feature of human lung CSCs, promoting metabolic adaption via the Notch1-AMPK axis to drive CSC expansion. Specifically, mitophagy is highly active in CSCs, resulting in increased mitochondrial DNA (mtDNA) content in the lysosome.

View Article and Find Full Text PDF
Article Synopsis
  • Dendritic cells (DCs) that help the body fight tumors don't work well in tumors because they are influenced by the environment around the tumor.
  • A protein called CH25H is really important for DCs to do their job, and when it's low, tumors grow faster and the body has a harder time fighting cancer.
  • Using special treatments that boost the activity of CH25H can help the DCs work better, improve the body's immune response, and make cancer treatments more effective.
View Article and Find Full Text PDF

Fragility of regulatory T (Treg) cells manifested by the loss of neuropilin-1 (NRP1) and expression of IFNγ undermines the immune suppressive functions of Treg cells and contributes to the success of immune therapies against cancers. Intratumoral Treg cells somehow avoid fragility; however, the mechanisms by which Treg cells are protected from fragility in the tumor microenvironment are not well understood. Here, we demonstrate that the IFNAR1 chain of the type I IFN (IFN1) receptor was downregulated on intratumoral Treg cells.

View Article and Find Full Text PDF
Article Synopsis
  • Evasion of tumor immunity and resistance to treatments in solid tumors is supported by an immunosuppressive tumor microenvironment (TME), characterized by factors like regulatory T cells and adenosine.
  • The study identified that these TME factors downregulate the IFNAR1 receptor on CD8 cytotoxic T lymphocytes (CTLs) through the action of PARP11, which is increased in CTLs within tumors.
  • Inhibition of PARP11 not only maintains IFNAR1 levels but also boosts CTL activity against tumors, enhancing the effectiveness of chimeric antigen receptor (CAR) T cell therapies.
View Article and Find Full Text PDF

Traditional Chinese medicine (TCM) is an essential part of the world's traditional medicine. However, there are still many issues in the promotion and development of TCM, such as a lot of unique TCM treatments are taught only between the master and an apprentice in practice, it takes dozens of years for a TCM practitioner to master them and the complicated TCM treatment principles. Intelligent TCM models, as a promising method, can overcome these issues.

View Article and Find Full Text PDF

Primary tumor-derived factors (TDFs) act upon normal cells to generate a pre-metastatic niche, which promotes colonization of target organs by disseminated malignant cells. Here we report that TDFs-induced activation of the p38α kinase in lung fibroblasts plays a critical role in the formation of a pre-metastatic niche in the lungs and subsequent pulmonary metastases. Activation of p38α led to inactivation of type I interferon signaling and stimulation of expression of fibroblast activation protein (FAP).

View Article and Find Full Text PDF

Internal tandem duplication within FLT3 (FLT3-ITD) is one of the most frequent mutations in acute myeloid leukemia (AML) and correlates with a poor prognosis. Whereas the FLT3 receptor tyrosine kinase is activated at the plasma membrane to transduce PI3K/AKT and RAS/MAPK signaling, FLT3-ITD resides in the endoplasmic reticulum and triggers constitutive STAT5 phosphorylation. Mechanisms underlying this aberrant FLT3-ITD subcellular localization or its impact on leukemogenesis remain poorly established.

View Article and Find Full Text PDF

Myeloid-derived suppressor cells (MDSC) are pathologically activated neutrophils and monocytes with potent immune suppressive activity. These cells play an important role in accelerating tumor progression and undermining the efficacy of anti-cancer therapies. The natural mechanisms limiting MDSC activity are not well understood.

View Article and Find Full Text PDF

Nineteen compounds were isolated and structurally characterized from an ethanol extract of Dendrobium gratiossimum, including dendrogratiol A(1), DDB-1(2), 3,4-dihydroxyl-5,3',4'-trimethoxybibenzyl(3), amoenylin(4), chrysotoxine(5), DTB(6), 3,4,4'-trihydroxyl-5,3'-dimethoxybenzyl(7), 3-methylgiga(8), aloifol(9), gigantol tetramethyl ether(10), batatasin Ⅲ(11), moscatilin(12), moniliformine(13), gigantol(14), DMB(15), flavanthrinin(16), cannithrene-2(17), 3,4-dihydroxyl-5,4'-dimethoxystilbene(18) and 4-hydroxy-3,5,4'-trimethoxystilbene(19). 1 was a new compound, and 2-10, 16, 18 and 19 were obtained from this plant species for the first time. In vitro cytotoxic and antiviral activities of these isolates were evaluated, which displayed that 4 showed moderate cytotoxicity against human hepatoma cell line HepG2 with the IC_(50) of 10.

View Article and Find Full Text PDF
Article Synopsis
  • Activation of cancer-associated fibroblasts (CAFs) and desmoplasia contribute significantly to the growth of solid tumors, particularly in colon and pancreatic cancers.
  • The study shows that downregulation of the IFNAR1 receptor is crucial for effective stromagenesis, as mice lacking this downregulation displayed impaired fibroblast activation and extracellular matrix production.
  • Analysis of human colorectal cancers indicates a negative correlation between IFNAR1 and fibroblast activation protein (FAP), suggesting that inactivation of IFNAR1 in CAFs promotes tumor growth and stromagenesis.
View Article and Find Full Text PDF

The quantitative understanding of human behavior is a key issue in modern science. Recently, inhomogeneous human activities have been described by bursts (consecutive activities separated by long periods of inactivity) and characterized by fat-tailed inter-event time (interval between two activities) distributions. However, the dynamics between number of activities and activity duration are still unclear.

View Article and Find Full Text PDF

Hyperactive oncogenic Myc stimulates protein synthesis that induces the unfolded protein response, which requires the function of the eukaryotic translation initiation factor 2-alpha kinase 3, also known as protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). Activated PERK acts to limit mRNA translation, enable proper protein folding, and restore the homeostasis in the endoplasmic reticulum. Given that Myc activation contributes to many types of lymphoid and myeloid human leukemias, we used a mouse model to examine the importance of PERK in development and progression of Myc-induced leukemias.

View Article and Find Full Text PDF

Tumor-derived extracellular vesicles (TEV) "educate" healthy cells to promote metastases. We found that melanoma TEV downregulated type I interferon (IFN) receptor and expression of IFN-inducible cholesterol 25-hydroxylase (CH25H). CH25H produces 25-hydroxycholesterol, which inhibited TEV uptake.

View Article and Find Full Text PDF

Purpose: Ablative hypofractionated radiation therapy (AHFRT) presents a therapeutic advantage compared with conventional fractionated radiation therapy (CFRT) for primary and oligometastatic cancers. However, the underlying mechanisms remain largely unknown. In the present study, we compared the immune alterations in response to AHFRT versus CFRT and examined the significance of immune regulations contributing to the efficacy of AHFRT.

View Article and Find Full Text PDF

Recent studies demonstrated that prolonged exposure of haematopoietic stem cells (HSCs) to type I interferons (IFN) stimulates HSCs entrance into cell cycle, continuous proliferation and eventual exhaustion, which could be prevented by ablation of the Ifnar1 chain of IFN receptor. Given that levels IFNAR1 expression can be robustly affected by IFN-independent ubiquitination and downregulation of IFNAR1 in response to activation of protein kinases such as protein kinase R-like endoplasmic reticulum kinase (PERK) and casein kinase 1α (CK1α), we aimed to determine the role of IFNAR1 downregulation in the maintenance of HSCs. Mice harboring the ubiquitination-deficient Ifnar1 allele displayed greater levels of haematopoietic cell progenitors but reduced numbers of the long-term HSCs compared with wild type mice and animals lacking Ifnar1.

View Article and Find Full Text PDF
Article Synopsis
  • The resistance of solid tumors, specifically colorectal cancers (CRCs), to immunotherapy is mainly due to an immunosuppressive environment that shields cancer cells from immune responses.
  • Research revealed that a receptor called IFNAR1, important for immune signaling, is downregulated in CRC, which contributes to tumor growth and poor prognosis.
  • Enhancing IFNAR1 through genetic or pharmacological means improved the survival of immune cells and boosted the effectiveness of certain immunotherapies, suggesting it could be a target for better cancer treatment.
View Article and Find Full Text PDF

Phototherapy with UV light is a standard treatment for psoriasis, yet the mechanisms underlying the therapeutic effects are not well understood. Studies in human and mouse keratinocytes and in the skin tissues from human patients and mice showed that UV treatment triggers ubiquitination and downregulation of the type I IFN receptor chain IFNAR1, leading to suppression of IFN signaling and an ensuing decrease in the expression of inflammatory cytokines and chemokines. The severity of imiquimod-induced psoriasiform inflammation was greatly exacerbated in skin of mice deficient in IFNAR1 ubiquitination (Ifnar1(SA)).

View Article and Find Full Text PDF

The great preclinical promise of the pancreatic endoplasmic reticulum kinase (PERK) inhibitors in neurodegenerative disorders and cancers is marred by pancreatic injury and diabetic syndrome observed in PERK knockout mice and humans lacking PERK function and suffering from Wolcott-Rallison syndrome. PERK mediates many of the unfolded protein response (UPR)-induced events, including degradation of the type 1 interferon (IFN) receptor IFNAR1 in vitro. Here we report that whole-body or pancreas-specific Perk ablation in mice leads to an increase in IFNAR1 protein levels and signaling in pancreatic tissues.

View Article and Find Full Text PDF